PROFUSA, INC. Unrealized Gain (Loss) on Derivatives
PROFUSA, INC. (PFSA) reported Unrealized Gain (Loss) on Derivatives of -$4.25 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-19.
Financial Statements › Cash Flow › Operating Activities
us-gaap:UnrealizedGainLossOnDerivatives · last filed 2026-08-19
- PROFUSA, INC. unrealized gain (loss) on derivatives for the quarter ending 2026-06-30 was -$4.25M.
- PROFUSA, INC. unrealized gain (loss) on derivatives for the quarter ending 2026-03-31 was -$797.00K.
- PROFUSA, INC. unrealized gain (loss) on derivatives for the quarter ending 2025-06-30 was -$153.00K.
- PROFUSA, INC. unrealized gain (loss) on derivatives for the quarter ending 2025-03-31 was -$156.00K.
| Period end | Unrealized Gain (Loss) on Derivatives 3 month | Unrealized Gain (Loss) on Derivatives 6 month |
|---|---|---|
| 2026-06-30 | -$4.25M 10-Q · filed 2026-08-19 | -$5.05M 10-Q · filed 2026-08-19 |
| 2026-03-31 | -$797.00K 10-Q · filed 2026-05-15 | |
| 2025-06-30 | -$153.00K 10-Q · filed 2026-08-19 | -$309.00K 10-Q · filed 2026-08-19 |
| 2025-03-31 | -$156.00K 10-Q · filed 2026-05-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Tenon Medical, Inc. (TNON) | United States | $0.002B | |
| Catheter Precision, Inc. (VTAK) | United States | $0.002B | -0.23 |
| INVO Fertility, Inc. (IVF) | United States | $0.002B | -0.71 |
| NEXGEL, INC. (NXGL) | United States | $0.002B | |
| Vivos Therapeutics, Inc. (VVOS) | United States | $0.003B | -0.26 |
| Beyond Air, Inc. (XAIR) | United States | $0.003B | -0.01 |
| Autonomix Medical, Inc. (AMIX) | United States | $0.004B | |
| Adagio Medical Holdings, Inc. (ADGM) | United States | $0.004B | |
| OSR Health, Inc. (OSRH) | United States | $0.004B | -0.75 |
| Bluejay Diagnostics, Inc. (BJDX) | United States | $0.004B |